MCF2L-AS1

gene
On this page

Summary

MCF2L-AS1 (MCF2L antisense RNA 1, HGNC:39825) is a long non-coding RNA gene on chromosome 13q34.

At a glance

  • Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:39825
Approved symbolMCF2L-AS1
NameMCF2L antisense RNA 1
Location13q34
Locus typeRNA, long non-coding
StatusApproved
Ensembl geneENSG00000235280
Ensembl biotypelncRNA
Entrez100289410
RNAcentralURS000075B876 — lncRNA, 1173 nt, 1 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 lncRNA

ENST00000446789

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000446789 — 2 exons

ExonStartEnd
ENSE00001623442112968619112968824
ENSE00001705172112967484112967989

Expression profiles

Bgee: expression breadth ubiquitous, 156 present calls, max score 82.02.

FANTOM5 (CAGE): breadth broad, TPM avg 1.0010 / max 31.1688, expressed in 503 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1383160.9734500
1383150.02759

Top tissues by expression

273 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
mucosa of transverse colonUBERON:000499182.02gold quality
adenohypophysisUBERON:000219680.84gold quality
pituitary glandUBERON:000000780.82gold quality
right hemisphere of cerebellumUBERON:001489077.86gold quality
cortical plateUBERON:000534377.85gold quality
islet of LangerhansUBERON:000000677.71gold quality
cerebellar hemisphereUBERON:000224577.32gold quality
cerebellar cortexUBERON:000212977.20gold quality
right uterine tubeUBERON:000130276.36gold quality
right lobe of liverUBERON:000111476.08gold quality
body of pancreasUBERON:000115075.88gold quality
lower esophagus mucosaUBERON:003583475.17gold quality
pancreasUBERON:000126475.03gold quality
cerebellumUBERON:000203774.93gold quality
apex of heartUBERON:000209873.75gold quality
rectumUBERON:000105273.67gold quality
metanephros cortexUBERON:001053372.80gold quality
ganglionic eminenceUBERON:000402372.30gold quality
olfactory segment of nasal mucosaUBERON:000538672.00gold quality
right frontal lobeUBERON:000281071.62gold quality
anterior cingulate cortexUBERON:000983571.46gold quality
body of stomachUBERON:000116171.44gold quality
minor salivary glandUBERON:000183071.41gold quality
cingulate cortexUBERON:000302771.38gold quality
left lobe of thyroid glandUBERON:000112071.11gold quality
saliva-secreting glandUBERON:000104470.39gold quality
right lobe of thyroid glandUBERON:000111970.28gold quality
transverse colonUBERON:000115769.93gold quality
thyroid glandUBERON:000204669.90gold quality
prefrontal cortexUBERON:000045169.66gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no2.69

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 7)

  • The lncRNA MCF2L-AS1 controls osteogenic differentiation by regulating miR-33a. (PMID:32255731)
  • LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis. (PMID:32860508)
  • Long non-coding RNA MCF2L-AS1 promotes the aggressiveness of colorectal cancer by sponging miR-874-3p and thereby up-regulating CCNE1. (PMID:33037865)
  • Long noncoding RNA MCF2L-AS1 promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulating miR-873-5p level. (PMID:33783940)
  • E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer. (PMID:36257058)
  • A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis. (PMID:36700469)
  • MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis. (PMID:37432067)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.